Our results demonstrate that IL-20 blockade by 7E is a promising treatment for PDAC with several advantages: (1) IL-20 is a prosurvival factor, and targeting IL-20 with 7E alone attenuated pancreatic cancer cell growth. This evidence concerns the gene IL20 and pancreatic neoplasm.